Douglas M. McCarty

机构：Pfizer (United States)

发表论文 84 篇 · 总被引 5036 次 · h-index 35

代表论文

• Evaluating the state of the science for adeno-associated virus integration: An integrated perspective (2022 · Molecular Therapy · 被引 209)
• Durability of transgene expression after rAAV gene therapy (2022 · Molecular Therapy · 被引 135)
• Biodistribution and Tolerability of AAV-PHP.B-CBh- SMN1 in Wistar Han Rats and Cynomolgus Macaques Reveal Different Toxicologic Profiles (2021 · Human Gene Therapy · 被引 62)
• Crossing the blood–brain-barrier with viral vectors (2016 · Current Opinion in Virology · 被引 57)
• A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design (2016 · Molecular Genetics and Metabolism · 被引 51)
• Production of rAAV by plasmid transfection induces antiviral and inflammatory responses in suspension HEK293 cells (2023 · Molecular Therapy — Methods & Clinical Development · 被引 47)